TPST (STOCKS)

    Tempest Therapeutics, Inc. Common Stock

    $0.640000
    +0.004800 (+0.76%)
    Prev close: $0.635200
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Matthew Angel
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $10.79M
    Employees
    5
    P/E (TTM)
    -0.14
    P/B (TTM)
    -9.31
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —

    Analyst Recommendations
    2
    Strong Buy
    4
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    $-0.34 $-0.31 -0.0340 -11.11%
    Mar 2026 (Q1)
    $-2.53 $-0.29 -2.2444 -785.85%
    Dec 2025 (Q4)
    $-0.62 $-0.63 +0.0124 +1.96%
    Sep 2025 (Q3)
    $-0.79 $-3.34 +2.5454 +76.31%